Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of ezetimibe and simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase mRNA expression in mononuclear cells: a randomized controlled study in healthy men

Trial Profile

Effects of ezetimibe and simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase mRNA expression in mononuclear cells: a randomized controlled study in healthy men

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2010

At a glance

  • Drugs Ezetimibe; Simvastatin
  • Indications Cardiovascular disorders; Cystic fibrosis; Diabetic cardiomyopathy; Hypercholesterolaemia; Hyperlipoproteinaemia; Hypertriglyceridaemia; Low HDL cholesterol; Multiple sclerosis; Sitosterolaemia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Sep 2010 Results were reported at the ESC Congress 2010: Annual Congress of the European Society of Cardiology.
    • 01 May 2008 Results published in Atherosclerosis.
    • 01 May 2008 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top